EARLY REFERRAL TO A HYPERTROPHIC CARDIOMYOPATHY CENTER OF EXCELLENCE MAY IMPROVE DIAGNOSTIC ACCURACY AND ENHANCE HEALTHCARE DELIVERY
Sneha Gadi(University of Virginia Health System), Christopher M. Kramer(American College of Cardiology), Elizabeth Farrar(University of Virginia Health System), Michael Ayers(University of Virginia)
Cited by 0
Related Papers
Criteria for Evaluation of Novel Markers of Cardiovascular Risk
|Circulation|2009|1.1k
Mavacamten Favorably Impacts Cardiac Structure in Obstructive Hypertrophic Cardiomyopathy
|Circulation|2020|234
Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy
|Journal of the American College of Cardiology|2023|192
Society for Cardiovascular Magnetic Resonance (SCMR) expert consensus for CMR imaging endpoints in clinical research: part I - analytical validation and clinical qualification
|Journal of Cardiovascular Magnetic Resonance|2018|153
2022 ACC/AHA guideline for the diagnosis and management of aortic disease
|Journal of Thoracic and Cardiovascular Surgery|2023|125